Brussels, Sep 3 (EFE).- The European Commission announced Friday it had closed legal proceedings against Anglo-Swedish drugmaker AstraZeneca.
The announcement came after rescheduling the delivery of the entirety of Covid-19 vaccines purchased by the EC, which the company had initially failed to deliver on time.
Under the new “settlement agreement,” AstraZeneca will supply 135 million doses by the end of the year, 60 million in September and another 75 million late into the last quarter of 2021.
The remaining 65 million doses are due in March 2022, the Commission said in a statement.
“AstraZeneca will provide member states on a rolling basis with weekly and monthly delivery schedules,” they said.
In the event of a delay to the new delivery schedules, capped rebates will be applied to the price of the doses, set at 10% for one month of delay, 25% for two months, and 40% for three months or more.
The rebates will not be granted if the delay is “beyond the reasonable control of AstraZeneca,” but the pharmaceutical will bear the burden of proof in such an event. EFE